[Unicocell] Application for Clinical Trial Design Change for ELIXCYTE
Unicocell announced on May 29, 2026, that it has applied to the Ministry of Health and Welfare to ch… · 2026-05-29
向榮生技 News Releases
[Ever Supreme Bio Technology] Announcement of Change in Internal Audit Supervisor
Ever Supreme Bio Technology announced that its internal audit supervisor, Mr. Liu Rui-yu, has resign… · 2026-05-22
UnicoCell Biomed Announces Newly Elected Board of Directors (Including Independent Directors) at 2026 Annual General Meeting
On May 20, 2026, UnicoCell Biomed announced a full re-election of its Board of Directors following t… · 2026-05-20
[UnicoCell Biomed] Announcement Regarding Changes to Audit Committee Members
UnicoCell Biomed announced on May 20, 115, changes to its Audit Committee members following the gene… · 2026-05-20
[UnicoCell Biotech] Announcement of Important Resolutions from the 2026 Annual General Meeting
UnicoCell Biotech held its annual general meeting on May 20, 2026, approving the 2025 fiscal year fi… · 2026-05-20
[Regeneration Biotech] Announcement of the Board's Election of Chairman
Regeneration Biotech announced that the Board of Directors has re-elected Tsai Yi-Wen as Chairman fo… · 2026-05-20
[Ever Supreme Bio Tech] Announcement of the Appointment of Remuneration Committee Members
Ever Supreme Bio Tech announced a reshuffle of its Remuneration Committee members following the expi… · 2026-05-20
[Ever Supreme Bio] Shareholders approve waiver of non-compete restrictions for directors
At the 2026/05/20 shareholder meeting, Ever Supreme Bio Technology approved the waiver of non-compet… · 2026-05-20
【Golden Biotechnology】Announcement of the Board of Directors' Approval of the Financial Report for Q1 2026
Golden Biotechnology's Board of Directors approved its financial report for Q1 2026 on May 8, 2026. … · 2026-05-08
【Golden Biotechnology】Announcement of the Board of Directors' Approval of the Financial Report for Q1 2026
Golden Biotechnology's Board of Directors approved its financial report for Q1 2026 on May 8, 2026. … · 2026-05-08
[Unicocell Biomed] May 2026 Revenue Reaches NT$1.425 Million (Up 52.4% YoY)
Unicocell Biomed (6794) announced its consolidated revenue for May 2026 at NT$1.425 million (approx.… · 2026-05-01
Encore Bio Announces Board Meeting Date for Q1 2026 Financial Report
Encore Bio has announced the schedule for its board meeting concerning the Q1 2026 financial report.… · 2026-04-30
Encore Bio Announces Board Meeting Date for Q1 2026 Financial Report
Encore Bio has announced the schedule for its board meeting concerning the Q1 2026 financial report.… · 2026-04-30
【Golden Biotechnology Corp.】Announcement of the Company's Board of Directors Resolution to Convene the 2026 Annual General Meeting of Shareholders (New Agenda Items Added)
Golden Biotechnology Corp. announced, following a board resolution on April 8, 2026, the addition of… · 2026-04-08
[Golden Biotechnology] Announcement of Board of Directors' Resolution to Issue Restricted Stock Units to Employees
Golden Biotechnology's board of directors resolved on April 8, 2026, to issue restricted stock units… · 2026-04-08
[Golden Biotechnology] Announcement of Board of Directors' Resolution to Issue Restricted Stock Units to Employees
Golden Biotechnology's board of directors resolved on April 8, 2026, to issue restricted stock units… · 2026-04-08
[Golden Biotechnology] Announcement of Board of Directors' Resolution to Issue Restricted Stock Units to Employees
Golden Biotechnology's board of directors resolved on April 8, 2026, to issue restricted stock units… · 2026-04-08
【Golden Biotechnology Corp.】Announcement of the Company's Board of Directors Resolution to Convene the 2026 Annual General Meeting of Shareholders (New Agenda Items Added)
Golden Biotechnology Corp. announced, following a board resolution on April 8, 2026, the addition of… · 2026-04-08
【Golden Biotechnology Corp.】Announcement of the Company's Board of Directors Resolution to Convene the 2026 Annual General Meeting of Shareholders (New Agenda Items Added)
Golden Biotechnology Corp. announced, following a board resolution on April 8, 2026, the addition of… · 2026-04-08
【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)
Medigen Biotechnology (6794) reported April 2026 revenue of 18.94 million yuan, a significant decrea… · 2026-04-01
【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)
Medigen Biotechnology (6794) reported April 2026 revenue of 18.94 million yuan, a significant decrea… · 2026-04-01
【UnicoCell Biomed】March 2026 Revenue NT$0.02 Billion (YoY -66.4%)
Biotechnology company UnicoCell Biomed (6794) announced that its monthly revenue for March 2026 was … · 2026-03-01
【UnicoCell Biomed】March 2026 Revenue NT$0.02 Billion (YoY -66.4%)
Biotechnology company UnicoCell Biomed (6794) announced that its monthly revenue for March 2026 was … · 2026-03-01
【Syngen Biotech】February 2026 Revenue: 0.03 Billion (YoY +186.2%)
Syngen Biotech (6794) has released its financial report for February 2026. The company's revenue for… · 2026-02-01
【Syngen Biotech】February 2026 Revenue: 0.03 Billion (YoY +186.2%)
Syngen Biotech (6794) has released its financial report for February 2026. The company's revenue for… · 2026-02-01